Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 51-60 of 95

Page
per page
  1. Puromycin dihydrochloride
    B7587 Puromycin dihydrochloride
    Summary: allows selection for cells expressing the resistance gene puromycin N-acetyl-transferase (PAC) and successful Cas9-induced knock-in with puromycin resistance gene.
      ≥27.2 mg/mL
  2. NU7441 (KU-57788)
    A8315 NU7441 (KU-57788)
     4 Citation
    Target: PI3K|DNA-PK
    Summary: DNA-PK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.13 mg/mL
  3. Fludarabine Phosphate (Fludara)
    A8317 Fludarabine Phosphate (Fludara)
     2 Citation
    Target: STAT
    Summary: Inhibits STAT1 activation and DNA synthesis
      insoluble in EtOH; ≥17.6 mg/mL
  4. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     1 Citation
    Summary: Chemotherapy agent, induces DNA strand break
      ≥125 mg/mL
  5. KU-60019
    A8336 KU-60019
     2 Citation
    Target: ATM/ATR
    Summary: ATM kinase inhibitor,potent and selective
      ≥27.4 mg/mL
  6. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL
  7. Cytarabine
    A8405 Cytarabine
     1 Citation
    Summary: cytotoxic agent, blocks DNA synthesis
      insoluble in EtOH; ≥28.6 mg/mL
  8. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  9. Tankyrase Inhibitors (TNKS) 49
    A8601 Tankyrase Inhibitors (TNKS) 49
    Target: Tankyrases
    Summary: Tankyrase inhibitor
      ≥22.45 mg/mL
  10. Acyclovir
    A8644 Acyclovir
    Target: HSV
    Summary: Antiviral agent
      insoluble in H2O; insoluble in EtOH; ≥11.4 mg/mL

Items 51-60 of 95

Page
per page
Relate Categories
Now Shopping by
  1. Category DNA Damage/DNA Repair Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Category
  1. MTH11 item
  2. PARP8item
  3. ATM/ATR4item
  4. DNA Alkylating3item
  5. DNA Methyltransferase1 item
  6. DNA-PK4item
  7. DNA Synthesis27item
  8. HDAC31item
  9. Nucleoside Antimetabolite/Analogue2item
  10. Telomerase1 item
  11. Topoisomerase14item
Specificity
  1. Selective63item
Reversibility
  1. Reversible3item
Target
  1. Histone Deacetylases (HDACs)30item
  2. PI3K4item
  3. MDM21 item
  4. Thymidylate Synthase2item
  5. STAT1 item
  6. Estrogen and Related Receptors1 item
  7. EGFR1 item
  8. Tankyrases1 item
  9. DNA-PK3item
  10. TNKS1 item
  11. Topoisomerases11item
  12. ErbB1 item
  13. DNA Methyltransferases1 item
  14. PARP6item
  15. ATM/ATR4item
  16. HSV1 item
  17. Synthases/Synthetases1 item
  18. RNA Polymerases1 item
  19. FoxM11 item
  20. O6-methylguanine-DNA-methyl-transferase (MGMT)1 item
  21. Adenine receptors1 item
  22. RNA synthesis1 item
  23. FPTase1 item
  24. p531 item
  25. HDAC1 item
  26. PPAR1 item
  27. HCV polymerase1 item
  28. Antibiotic1 item
  29. DNA Alkylating2item
  30. Telomerases1 item
  31. Ribonucleotide Reductases1 item
  32. PTK1 item
  33. Adenosine Deaminases1 item
  34. DNA gyrase1 item
  35. 5-HT1 item
  36. ATM1 item
  37. MTH11 item
Related Disease
  1. Acute Myelogenous Leukemia2item
  2. Acute Myeloid Leukemia2item
  3. Bladder Cancer4item
  4. Breast Cancer17item
  5. Cancer64item
  6. Chronic Lymphocytic Leukemia1 item
  7. Colon Cancer8item
  8. Colon Carcinoma1 item
  9. Colorectal Cancer7item
  10. Dyskinesia1 item
  11. Epilepsy1 item
  12. Friedreich's Ataxia1 item
  13. Glioblastoma2item
  14. Glioma2item
  15. HCV1 item
  16. Hepatic Cancer1 item
  17. Hepatocellular Carcinoma3item
  18. HIV Infections1 item
  19. Inflammatory Diseases1 item
  20. Leukemia7item
  21. Liver Cancer1 item
  22. Lung Cancer6item
  23. Lymphoma6item
  24. Melanoma5item
  25. Multiple Myeloma3item
  26. Myeloma2item
  27. Neuroblastoma2item
  28. Neuronal Protection1 item
  29. Non-small Cell Lung Cancer3item
  30. Ovarian Cancer7item
  31. Pancreatic Cancer3item
  32. Prostate Cancer10item
  33. Renal Cancer1 item
  34. Renal Cell Carcinoma2item
  35. Testicular Cancer1 item